Literature DB >> 8462885

Blood-retinal barrier permeability and its relation to progression of retinopathy in patients with type 2 diabetes. A four-year follow-up study.

J Cunha-Vaz1, E Leite, J C Sousa, J R de Abreu.   

Abstract

Forty patients with late-onset diabetes (age at diagnosis 30 years or more) and minimal retinopathy as found by fundus photography were followed prospectively by repeated examination (baseline, 1 year, and 4 years). The study shows that early retinopathy changes are not permanent or invariably progressive. In the 1st year of follow-up microaneurysms worsened in 25%, improved in 10%, and remained stabilized in 65%. Vitreous fluorometry was able to detect an overall increase of 0.84 +/- 1.06 x 10(-6) min-1 in blood-retinal barrier (BRB) penetration ratios. After 4 years, 16 of the 40 patients had undergone photocoagulation (focal photo-coagulation in 11 and pan retinal photocoagulation in 5). The eyes that needed photocoagulation were the eyes that had higher fluorometry penetration ratios at the patient's entry into the study and showed a higher rate of deterioration during the 1st year of the study (5.54 +/- 1.97 vs 3.11 +/- 1.22 x 10(-6) min-1, P < 0.001, initial values; 1.52 +/- 0.76 vs 0.45 +/- 0.99 x 10(-6) min-1, P < 0.001, annual increase in leakage). The eyes that did not need photocoagulation, 24 out of 40, showed stable fluorometry readings within the 4-year period of follow-up (+0.02 +/- 0.98 10(-6) min-1). Abnormally high vitreous fluorometry values and their rapid increase over time appear to be good indicators of rapid progression and worsening of the retinopathy.

Entities:  

Mesh:

Year:  1993        PMID: 8462885     DOI: 10.1007/bf00920936

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  10 in total

1.  Vitreous fluorophotometry: mathematical analysis of the effect of peripheral leakage on axial scans.

Authors:  P Dalgaard; V A Barker; H Lund-Andersen
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-07       Impact factor: 4.799

2.  Diabetic retinopathy. Human and experimental studies.

Authors:  J G Cunha-Vaz
Journal:  Trans Ophthalmol Soc U K       Date:  1972

3.  Vitreous fluorophotometry for clinical research. I. Description and evaluation of a new fluorophotometer.

Authors:  R C Zeimer; N P Blair; J G Cunha-Vaz
Journal:  Arch Ophthalmol       Date:  1983-11

4.  Early breakdown of the blood-retinal barrier in diabetes.

Authors:  J Cunha-Vaz; J R Faria de Abreu; A J Campos
Journal:  Br J Ophthalmol       Date:  1975-11       Impact factor: 4.638

5.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12

6.  Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study.

Authors:  C Engler; B Krogsaa; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

7.  Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy.

Authors: 
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-07       Impact factor: 4.799

8.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1989-02

9.  The blood-retinal barrier permeability to fluorescein in normal subjects and in juvenile diabetics without retinopathy.

Authors:  B Krogsaa; H Lund-Andersen; J Mehlsen; L Sestoft
Journal:  Acta Ophthalmol (Copenh)       Date:  1986-04

10.  Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry.

Authors:  J G Cunha-Vaz; J R Gray; R C Zeimer; M C Mota; B M Ishimoto; E Leite
Journal:  Diabetes       Date:  1985-01       Impact factor: 9.461

  10 in total
  5 in total

1.  Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

Authors:  H J Van Schaik; B Heintz; M Larsen; E Leite; V Rosas; R Schalnus; J A Van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

2.  Distinct glycolysis inhibitors determine retinal cell sensitivity to glutamate-mediated injury.

Authors:  A C Rego; F M Areias; M S Santos; C R Oliveira
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

3.  Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetics. A 4-year follow-up study.

Authors:  A Castillo; J M Benitez del Castillo; D Diaz; O Sayagues; J L Ruibal; J Garcia-Sanchez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

4.  Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.

Authors:  Maria L Ribeiro; Andras I Seres; Angela M Carneiro; Michael Stur; Alain Zourdani; Patricia Caillon; José G Cunha-Vaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

Review 5.  The Role of Retinal Pigment Epithelial Cells in Regulation of Macrophages/Microglial Cells in Retinal Immunobiology.

Authors:  Andrew W Taylor; Samuel Hsu; Tat Fong Ng
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.